These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 387230)

  • 21. A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
    Howell A; Rubens RD; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Hayward JL; Knight RK; Bulbrook RD
    Recent Results Cancer Res; 1984; 96():74-89. PubMed ID: 6396780
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC; Paridaens R
    Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
    [No Abstract]   [Full Text] [Related]  

  • 23. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
    Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
    Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience.
    Carbone PP
    Breast Cancer Res Treat; 1983; 3 Suppl():S35-8. PubMed ID: 6367858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
    Rivkin SE; Glucksberg H; Foulkes M
    Recent Results Cancer Res; 1984; 96():166-74. PubMed ID: 6396770
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
    Henderson IC
    J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
    [No Abstract]   [Full Text] [Related]  

  • 27. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
    Fisher B; Redmond C; Legault-Poisson S; Dimitrov NV; Brown AM; Wickerham DL; Wolmark N; Margolese RG; Bowman D; Glass AG
    J Clin Oncol; 1990 Jun; 8(6):1005-18. PubMed ID: 2189950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.
    Rossi A; Valagussa P; Bonadonna G
    Prog Clin Biol Res; 1977; 12():391-404. PubMed ID: 335401
    [No Abstract]   [Full Text] [Related]  

  • 29. Is there a place for adjuvant endocrine therapy of breast cancer?
    Meakin JW
    Recent Results Cancer Res; 1980; 71():178-84. PubMed ID: 7367731
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of a natural history data base to compare outcome among several trials of adjuvant chemotherapy for stage II breast cancer.
    Jones SE; Moon TE
    Recent Results Cancer Res; 1984; 96():148-54. PubMed ID: 6396768
    [No Abstract]   [Full Text] [Related]  

  • 31. Ovarian function in patients receiving adjuvant chemotherapy for breast cancer.
    Rose DP; Davis TE
    Lancet; 1977 Jun; 1(8023):1174-6. PubMed ID: 68275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for advanced male breast cancer.
    Yap HY; Tashima CK; Blumenschein GR; Hortobagyi GN; Eckles N
    JAMA; 1980 May; 243(17):1739-41. PubMed ID: 7365938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adjuvant chemotherapy in breast cancer].
    Senn HJ
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1626-30. PubMed ID: 7030686
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathologic findings from the National Surgical Adjuvant Breast Project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation.
    Fisher ER; Redmond C; Fisher B
    Cancer; 1983 Jan; 51(2):181-91. PubMed ID: 6821810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy in breast cancer: no news.
    Goldstein G; Webb RN
    Lancet; 1983 Apr; 1(8328):816. PubMed ID: 6132145
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
    Carter SK
    Postgrad Med; 1985 Jan; 77(1):75-7, 80-3. PubMed ID: 3880891
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adjuvant chemotherapy of breast cancer].
    Schmidt CG
    Med Welt; 1976 May; 27(21):1033-6. PubMed ID: 778534
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sentinel lymph node and neoadjuvant therapy in breast cancer: searching for the best scenario].
    Solá M; Fraile M
    Rev Esp Med Nucl; 2010; 29(6):316-8. PubMed ID: 21055516
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant chemotherapy for breast cancer: an overview of NSABP findings.
    Fisher B; Redmond C; Elias EG; Evans J; Foster R; Jochimsen P; Lawrence W; Lerner H; LiCalzi N; Margolese R; Poisson R; Sachs S; Shibata H; Sutherland C; Wallack M
    Int Adv Surg Oncol; 1982; 5():65-90. PubMed ID: 7047408
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancer.
    Hansen M; Palshof T; Osterlind K; Hansen HH; Mouridsen H
    Cancer Treat Rep; 1977 Nov; 61(8):1603-5. PubMed ID: 922762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.